FORNARO, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 243
EU - Europa 114
AS - Asia 83
AF - Africa 8
Totale 448
Nazione #
US - Stati Uniti d'America 238
SG - Singapore 67
IT - Italia 47
DE - Germania 44
CI - Costa d'Avorio 8
CN - Cina 6
FI - Finlandia 6
IN - India 6
CA - Canada 5
FR - Francia 4
NL - Olanda 4
GB - Regno Unito 3
IE - Irlanda 3
HK - Hong Kong 2
BE - Belgio 1
GR - Grecia 1
JP - Giappone 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 448
Città #
Singapore 53
Chandler 47
Ashburn 31
Santa Clara 25
Seattle 15
Milan 14
Naples 14
Rome 7
Karlsruhe 5
Los Angeles 5
Weng 5
Amsterdam 4
Munich 4
Pune 4
Boston 3
Dublin 3
Foggia 3
Freiburg im Breisgau 3
Helsinki 3
Lappeenranta 3
Lawrence 3
Bhundsi 2
Council Bluffs 2
Dallas 2
Des Moines 2
Esslingen am Neckar 2
Guangzhou 2
Houston 2
Kronberg 2
London 2
Millbury 2
Affing 1
Angri 1
Beijing 1
Brussels 1
Germantown 1
Hachenburg 1
Kagoya 1
Krefeld 1
Montesarchio 1
Montreal 1
Ottawa 1
Paris 1
Rietheim-Weilheim 1
Riyadh 1
Schoenwalde 1
Union City 1
Vancouver 1
Yinchuan 1
Totale 292
Nome #
Two is better than one: effectiveness of dupilumab on atopic dermatitis and chronic rhinosinusitis with nasal polyps in an adolescent 38
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 29
Herpes Zoster and Alopecia Areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects 29
Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies? 28
Onset of vitiligo in a psoriasis patient on ixekizumab 25
A case of pediatric psoriasis successfully and rapidly treated with ixekizumab 25
Effects of COVID-19 pandemic on malignant melanoma diagnosis 23
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 22
Abrocitinib in atopic dermatitis: review of the current literature and clinical trials 21
The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders 18
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al 17
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge 17
Tattooing and hidradenitis suppurativa: stigmatization and camouflage 16
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data 16
A case of psoriasis and multiple sclerosis succesfully treated with concomitant fingolimod and secukinumab 16
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? 15
Step by step surgery for Hidradenitis Suppurativa 13
Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511” 12
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre 12
Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation 11
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation 11
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis 10
Asymptomatic microscopic colitis induced by secukinumab 10
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review 9
Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge 8
The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area 8
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation 7
Management of Advanced Invasive Melanoma: New Strategies 7
Totale 473
Categoria #
all - tutte 3.704
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 10 0 0 0 0 0 0 0 1 3 7
2022/2023142 4 1 7 19 32 19 1 13 16 7 11 12
2023/2024188 6 28 23 11 13 21 5 27 3 3 21 27
2024/2025122 39 25 9 4 36 9 0 0 0 0 0 0
Totale 473